Probing the Effect of the Non-Active-Site Mutation Y229W in New Delhi Metallo-β-lactamase-1 by Site-Directed Mutagenesis, Kinetic Studies, and Molecular Dynamics Simulations

New Delhi metallo-β-lactmase-1 (NDM-1) has attracted extensive attention for its high catalytic activities of hydrolyzing almost all β-lactam antibiotics. NDM-1 shows relatively higher similarity to subclass B1 metallo-β-lactmases (MβLs), but its residue at position 229 is identical to that of B2/B3 MβLs, which is a Tyr instead of a B1-MβL-conserved Trp. To elucidate the possible role of Y229 in the bioactivity of NDM-1, we performed mutagenesis study and molecular dynamics (MD) simulations. Although residue Y229 is spatially distant from the active site and not contacting directly with the substrate or zinc ions, the Y229W mutant was found to have higher kcat and Km values than those of wild-type NDM-1, resulting in 1∼7 fold increases in kcat/Km values against tested antibiotics. In addition, our MD simulations illustrated the enhanced flexibility of Loop 2 upon Y229W mutation, which could increase the kinetics of both substrate entrance (kon) and product egress (koff). The enhanced flexibility of Loop 2 might allow the enzyme to adjust the geometry of its active site to accommodate substrates with different structures, broadening its substrate spectrum. This study indicated the possible role of the residue at position 229 in the evolution of NDM-1.

[1]  Hua Guo,et al.  Characterization of purified New Delhi metallo-β-lactamase-1. , 2011, Biochemistry.

[2]  Ju-Guang Han,et al.  Probing ligand-binding modes and binding mechanisms of benzoxazole-based amide inhibitors with soluble epoxide hydrolase by molecular docking and molecular dynamics simulation. , 2012, The journal of physical chemistry. B.

[3]  Jürgen Pleiss,et al.  Insight into the mechanism of the IMP-1 metallo-beta-lactamase by molecular dynamics simulations. , 2003, Protein engineering.

[4]  Jürgen Pleiss,et al.  Insight into the mechanism of the IMP-1 metallo-β-lactamase by molecular dynamics simulations , 2003 .

[5]  G. Bou,et al.  Beta-lactamase inhibitors: the story so far. , 2009, Current medicinal chemistry.

[6]  N. Strynadka,et al.  New Delhi metallo-β-lactamase: structural insights into β-lactam recognition and inhibition. , 2012, Journal of the American Chemical Society.

[7]  Yong Chen,et al.  A quantum mechanics/molecular mechanics study on the hydrolysis mechanism of New Delhi metallo-β-lactamase-1 , 2013, Journal of Computer-Aided Molecular Design.

[8]  Molecular dynamics and free energy studies on the carboxypeptidases complexed with peptide/small molecular inhibitor: mechanism for drug resistance. , 2012, Insect biochemistry and molecular biology.

[10]  J. Frère,et al.  Biochemical Characterization of the Pseudomonas aeruginosa 101/1477 Metallo-β-Lactamase IMP-1 Produced byEscherichia coli , 1999, Antimicrobial Agents and Chemotherapy.

[11]  Liam J. Worrall,et al.  New Delhi Metallo-Beta-Lactamase: Structural Insights into Beta-Lactam Recognition and Inhibition , 2012 .

[12]  P. Kollman,et al.  A well-behaved electrostatic potential-based method using charge restraints for deriving atomic char , 1993 .

[13]  H. Giamarellou,et al.  Multidrug-Resistant Gram-Negative Infections are the Treatment Options? , 2009 .

[14]  J. Frère,et al.  Standard numbering scheme for class B beta-lactamases. , 2001, Antimicrobial agents and chemotherapy.

[15]  Hwangseo Park,et al.  Hybrid QM/MM and DFT investigations of the catalytic mechanism and inhibition of the dinuclear zinc metallo-beta-lactamase CcrA from Bacteroides fragilis. , 2005, Journal of the American Chemical Society.

[16]  M. Sparta,et al.  The Role of the Flexible L43-S54 Protein Loop in the CcrA Metallo-β-lactamase in Binding Structurally Dissimilar β-Lactam Antibiotics. , 2013, Journal of chemical theory and computation.

[17]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[18]  R. Schmid,et al.  Modeling domino effects in enzymes: molecular basis of the substrate specificity of the bacterial metallo-beta-lactamases IMP-1 and IMP-6. , 2003, Biochemistry.

[19]  A. Buschiazzo,et al.  Evidence of adaptability in metal coordination geometry and active-site loop conformation among B1 metallo-beta-lactamases . , 2010, Biochemistry.

[20]  Timothy R. Walsh,et al.  Characterization of a New Metallo-β-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India , 2009, Antimicrobial Agents and Chemotherapy.

[21]  D. Wareham,et al.  A Novel Variant, NDM-5, of the New Delhi Metallo-β-Lactamase in a Multidrug-Resistant Escherichia coli ST648 Isolate Recovered from a Patient in the United Kingdom , 2011, Antimicrobial Agents and Chemotherapy.

[22]  Youngchang Kim,et al.  NDM‐1, the ultimate promiscuous enzyme: substrate recognition and catalytic mechanism , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  Yuan-Ping Pang,et al.  Novel Zinc Protein Molecular Dynamics Simulations: Steps Toward Antiangiogenesis for Cancer Treatment , 1999 .

[24]  N. Woodford,et al.  Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study , 2010, The Lancet. Infectious diseases.

[25]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .

[26]  C. Bebrone Metallo-beta-lactamases (classification, activity, genetic organization, structure, zinc coordination) and their superfamily. , 2007, Biochemical pharmacology.

[27]  Cheng Luo,et al.  Molecular Basis of NDM-1, a New Antibiotic Resistance Determinant , 2011, PloS one.

[28]  Wanzhi Huang,et al.  Analysis of the Functional Contributions of Asn233 in Metallo-β-Lactamase IMP-1 , 2011, Antimicrobial Agents and Chemotherapy.

[29]  S. Kingsmore,et al.  Molecular dynamic simulations of the metallo-beta-lactamase from Bacteroides fragilis in the presence and absence of a tight-binding inhibitor , 2009, Journal of molecular modeling.

[30]  Hui Chen,et al.  Inhibitor Discovery of Full-Length New Delhi Metallo-β-Lactamase-1 (NDM-1) , 2013, PloS one.

[31]  P. Nordmann,et al.  NDM-4 Metallo-β-Lactamase with Increased Carbapenemase Activity from Escherichia coli , 2012, Antimicrobial Agents and Chemotherapy.

[32]  Moreno Galleni,et al.  Standard Numbering Scheme for Class B β-Lactamases , 2001, Antimicrobial Agents and Chemotherapy.

[33]  T. Palzkill Metallo‐β‐lactamase structure and function , 2013, Annals of the New York Academy of Sciences.

[34]  Quan Hao,et al.  Crystal structure of NDM‐1 reveals a common β‐lactam hydrolysis mechanism , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[36]  L. Hsu,et al.  World Health Day 2011: combating antimicrobial resistance. , 2011, Singapore medical journal.

[37]  Honggang Zhou,et al.  A structural view of the antibiotic degradation enzyme NDM-1 from a superbug , 2011, Protein & Cell.

[38]  Michael W Crowder,et al.  Mechanistic and spectroscopic studies of metallo-β-lactamase NDM-1. , 2012, Biochemistry.

[39]  B. Brooks,et al.  An analysis of the accuracy of Langevin and molecular dynamics algorithms , 1988 .

[40]  G. Bou,et al.  Beta-lactamase inhibitors: the story so far. , 2009, Current medicinal chemistry.

[41]  J. Frère,et al.  Role of Cys221 and Asn116 in the zinc-binding sites of the Aeromonas hydrophila metallo-β-lactamase , 2003, Cellular and Molecular Life Sciences CMLS.